home All News open_in_new Full Article

Rakovina Therapeutics and Variational AI Strengthen Partnership

Strategic Funding Led by Nimbus Synergies, Backed by Merck GHI, to Accelerate AI-Powered Collaborations VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing cancer therapies based on DNA-damage response technologies, proudly reaffirms its strategic partnership with Variational AI. This announcement comes on the heels […]


today 4 h. ago attach_file Culture

attach_file Economics
attach_file Economics
attach_file Science
attach_file Culture
attach_file Events
attach_file Events
attach_file Culture
attach_file Other
attach_file Other
attach_file Other
attach_file Culture
attach_file Events
attach_file Economics
attach_file Politics
attach_file Sport
attach_file Culture
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Other


ID: 3002257764
Add Watch Country

arrow_drop_down